Viewing Study NCT02680795

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:16 PM
Ignite Modification Date: 2026-02-24 @ 10:44 AM
Study NCT ID: NCT02680795
Status: COMPLETED
Last Update Posted: 2025-10-17
First Post: 2016-02-09
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Establish the PK of Belinostat in Patients With Wild-type, Heterozygous, and Homozygous UGT1A1*28 Genotypes
Sponsor: Acrotech Biopharma Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumors View
None Hematological Malignancies View
Keywords:

Keywords

Keyword Brief Keyword Text View
None UGT1A1*28 View
None Belinostat View
None beleodaq View
None wild type genotypes View
None heterozygous genotypes View
None homozygous genotypes View